|
|
|
|
|
|
|
|
|
|
$8.68M in early researcher awards announced in Ontario | Laboratory Product News
UNIVERSITY OF WATERLOO
Project title: Rational design of novel surface active compound for improving non-viral DNA transfection efficiencies. Lead researcher: Dr Shawn Wettig. Gene therapy uses DNA to treat disease. While it shows great promise, creating a delivery system to deliver DNA to specific areas in the body is a challenge. Dr Wettig is working to develop delivery systems, starting with one for ovarian cancer, the leading cause of death among gynecological cancers.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.